Implant system and method for manufacturing an implant system - Patents.com

The bioabsorbable implant system with a geometrically stable capsule element addresses the limitations of conventional implants by providing stable tissue support and controlled integration, promoting regeneration while avoiding foreign body reactions and leakage, through a combination of biodegradable materials and controlled substance exchange.

JP2024545237APending Publication Date: 2024-12-05KARL LEIBINGER ASSET MANAGEMENT GMBH & CO KG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024535758
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-22
Filing Date
2022-11-30
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Conventional implants for soft tissue reconstruction and augmentation are non-biodegradable, leading to foreign body reactions, immunological complications, and potential leakage, especially in large defects, with bioabsorbable implants having unfavorable volume-to-mass ratios and causing additional issues.

Method used

A bioabsorbable implant system comprising a geometrically stable capsule element with defined passage openings, allowing for tissue reception and gradual resorption, featuring a three-dimensional interior space and optional membrane barriers to control cell migration and substance exchange, manufactured through thermoforming or additive methods, using biodegradable polymers and potentially incorporating therapeutic particles.

Benefits of technology

The implant system provides stable tissue support during healing, promotes tissue regeneration, minimizes inflammatory responses, and eliminates the need for removal by gradual absorption, ensuring geometric stability and controlled tissue integration.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024545237000001_ABST
    Figure 2024545237000001_ABST
Patent Text Reader

Abstract

The present invention relates to an implant system (100) comprising at least one bioabsorbable capsule element (110) designed with a passage opening (113) and defining a three-dimensional internal space (120) for receiving soft tissue. Furthermore, the implant system can have an inner element which is or can be positioned at least partially within the three-dimensional internal space (120) defined by the capsule element (110) and which has at least one guide structure for cell migration. Furthermore, the present invention relates to a method for manufacturing the implant system (100).
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to an implant system and a method for manufacturing an implant system, which may in particular be an absorbable, geometrically stable implant system for functional improvement of large volume soft tissue defects or breast reconstruction. [Background technology]

[0002] Conventional implants for the reconstruction of large soft tissue defects (e.g. breast reconstruction) or for functional improvement of large soft tissue defects are not biodegradable and therefore remain as foreign bodies at the patient site. Bioabsorbable implants made of heterogeneous materials have so far only been possible for very small defects, and such implants often have a disadvantageously low volume-to-mass ratio, i.e. are excessively heavy for the desired volume. Rejection or inflammatory reactions can lead to immunological complications. Such effects can be exacerbated by aging of the implant material if it is not bioabsorbable. Such aging can also lead to leakage of the implant, which can sometimes require revision of the implant. Summary of the Invention [Problem to be solved by the invention]

[0003] The object of the present invention is to provide an improved implant system for the reconstruction or functional improvement of soft tissue defects, which overcomes the above mentioned problems or at least reduces the consequences thereof.

[0004] This object is achieved by an implant system having the features of claim 1. It is further an object to provide a method for manufacturing such an implant system. This object is achieved by a method having the features of claim 12. [Means for solving the problem]

[0005] Correspondingly, according to a first aspect of the present invention, there is provided an implant system comprising at least one bioabsorbable capsule element configured with a passage opening and defining a three-dimensional interior space for receiving soft tissue, which may for example be adipose tissue and / or connective tissue, in particular for breast reconstruction or augmentation.

[0006] The implant system is preferably intended for use in a mammal, especially a human patient. When "a patient" or "a patient" is referred to herein and hereinafter, this is meant to include both male and female patients. In particular, where implants for breast reconstruction are concerned, female patients are of interest. Indeed, implants for breast reconstruction are described herein as a general example.

[0007] In the context of this specification, "bioabsorbable" is intended to mean that the corresponding bioabsorbable element (here, the capsule element) is not only very well tolerated by the body in which it is implanted, but is also gradually absorbed by the body. In particular, this has the advantage that the implant does not necessarily have to be removed again later, but is completely absorbed and / or replaced, for example, by endogenous regrown tissue. In the following, both the terms "bioabsorbable" and "biodegradable" are used. "Bioabsorbable" essentially means the physiological absorption of degradation products by cells, while "biodegradable" refers to a mainly extracellular degradation without physiological uptake of the degradation products. Thus, in the context of the present invention, the two terms are interchangeable insofar as an element described as "bioabsorbable" can be configured to be (as an alternative or additionally) "biodegradable" and vice versa.

[0008] The defined three-dimensional internal space may have any desired shape, for example a hemispherical shape or the shape of a part of a sphere. However, other shapes may be envisaged, depending on which soft tissue is intended to be received in which body at which position. In this case, the purpose of the implant system is in particular to receive the soft tissues, generate a cavity with a stable volume and fix them in place, at least during the healing process and the gradual resorption of the capsule elements. As will be explained in more detail below, the capsule elements may perform further tasks, for example promoting or stimulating tissue regeneration. This may also be further facilitated by other elements and properties of the implant system. In this case, in particular, certain implant embodiments in combination with a membrane barrier may allow site-specific inward cell migration and may control inward cell migration. The membrane forming the membrane barrier can be or is specifically fixed on the defined implant structure.

[0009] The capsule element is so named because, in particular during use in the patient's body, it encapsulates (completely or at least partially) the soft tissue received in the interior space, thus not only fixing the soft tissue, but also protecting and possibly even isolating it from external influences. The passage opening of the capsule element is used to exchange substances between the interior and the exterior, which is on the opposite side of the capsule element and is also still located in the patient's body. In this way, for example, cells can migrate inwards, body fluids can be exchanged, blood vessels can grow through the passage opening, and / or the like. The size of one or more of the passage openings can be adapted corresponding to the desired function and the substance and / or tissue part to be exchanged. In addition, the implant system, in particular the capsule element, can be covered with a membrane to act as a diffusion barrier. In this case, the membrane can have a different degradation profile than the actual implant system. This prevents inflammatory cells from migrating inwards prematurely. Only after the degradation of the membrane can tissue-specific cells migrate inwards, after the primary inflammatory reaction has subsided.

[0010] The capsule element is preferably configured to be geometrically stable, i.e., its shape is only lost (at most) gradually and in a defined manner in the course of gradual biodegradation and bioabsorption by the body into which it is implanted, but advantageously is not substantially lost by forces acting on the capsule element from the very beginning in the implantation situation. Thus, the implant system according to the invention differs from so-called "injectables", which do not have geometric stability even at the beginning of implantation. Geometric stability against thermal deformations up to at least 60° C. is likewise preferred.

[0011] According to a second aspect, the present invention provides a method for producing an implant system, comprising: measuring an anatomical structure of a human patient to obtain anatomical data; creating a patient-specific implant system based on the anatomical data.

[0012] The capsule element of the implant system may be preferably manufactured by thermoforming (sometimes also known as "deep drawing"). The passage opening may be introduced in a defined manner by subtractive methods directly during the deep drawing process (as "primary passage opening") and / or afterwards (as "secondary passage opening"). The inner element may also be made by additive manufacturing techniques and may be connected or connectable to the capsule element on a specific retention structure. Furthermore, both the inner element and the capsule element may be manufactured patient-specific. The capsule element and / or the inner element may be composed either of the same raw material or a combination of different materials, which may, for example, allow the internal space to be colonized by tissue more quickly and may ensure that the capsule element remains geometrically stable for a certain period of time until it is finally absorbed.

[0013] According to a third aspect, the present invention provides a method of fixating soft tissue within a patient, comprising: - installing an implant system according to an embodiment of the first aspect of the invention in a patient's body; and moving the soft tissue and / or the implant system such that the three-dimensional interior space defined by the capsule element receives the soft tissue.

[0014] Depending on whether the soft tissue is already connected to the patient's body, the soft tissue may be introduced into the implant system, i.e., into the interior space defined by the capsule element, before the implant system is introduced into the patient's body, or the introduction may be performed in the reverse order or simultaneously.

[0015] Advantageous and preferred embodiments, embodiment variants or improvements are explained in more detail in the dependent claims and the following description, particularly with reference to the drawings. According to some preferred embodiments, embodiment variants or improvements, the three-dimensional internal space is defined by the three-dimensional curvature of the capsule element and is at least partially surrounded by the three-dimensional curvature. If the three-dimensional internal space is configured, for example, hemispherically, the capsule element can be formed in the shape of a hemispherical shell. The capsule element can completely surround the three-dimensional internal space, for example, to ensure a certain stability, or alternatively, the capsule element can only partially surround the three-dimensional internal space, such that an entrance opening remains, through which, for example, soft tissue can be introduced into the internal space. Compared to other options for defining the internal space, the curvature is particularly natural and can therefore ideally fit various tissue parts in the patient's body, cause little irritation and give a natural feel.

[0016] According to some preferred embodiments, embodiment variants or improvements, the bioabsorbable capsule element is configured as a capsule element that is geometrically stable before the onset of bioabsorption. In some variants, the inner element may alternatively or additionally be configured as a geometrically stable inner element, for example to provide additional stability to the implant system. The change in geometric stability over time due to bioabsorption can be tailored in an application- and patient-specific manner by appropriate selection of materials and geometries.

[0017] According to some preferred embodiments, embodiment variants or improvements, the passage openings are provided by pores and / or by a matrix-like lattice. The pores and / or the matrix-like lattice can in this case advantageously be technically minimized, i.e. in particular selected and configured such that the amount of implant material used is minimized while ensuring the desired strength and stability of the capsule element. In this way, for example, the ratio between the volume of the three-dimensional interior space and the mass of the implant system, in particular the capsule element, can be advantageously increased. Thus, the passage openings of the capsule element are used not only for the passage of substances or tissue parts, but also for material and weight reduction of the capsule element.

[0018] The passage openings may also be arranged in site-specific patterns, for example, passage openings oriented at the edge, in the center, or to one side. Additionally, absorption kinetics may be tailored by the particular configuration of the passage openings.

[0019] If the passage openings are at least partially formed by pores, the pores may be at least partially uniformly arranged. That is, there may be at least one partial region of the capsule element in which the pores are arranged at regular intervals or in a regular pattern. Meanwhile, in one or more other regions of the capsule element, the pores may be arranged more densely or more spread out relative to the pattern, in which case the corresponding locations may be coordinated with the tissues arranged inside or outside the interior space. In other words, if an increase in the penetration of the capsule element by soft tissues or an increase in the exchange of substances through the capsule element is desired, the arrangement of pores may be provided with a higher frequency and / or with larger pores than in another place of the capsule element where less exchange or less penetration is desired. In other words, both the distance between the pores and the dimensions of the pores themselves, i.e. in particular the diameter, may be different at various positions of the capsule element, i.e. they may vary throughout the capsule element. The same applies to a matrix-like lattice of passage openings, in which case the passage openings may be configured as squares or rectangles. The passage openings configured as oval or circular pores may also be arranged in a grid.

[0020] According to some preferred embodiments, embodiment variants or improvements, the capsule element comprises or consists of a biodegradable polymer. Also advantageously, the capsule element may comprise or consist of a biodegradable polymer composite. In this case, it is particularly preferred that the capsule element comprises or consists of a biodegradable polyester or comprises or consists of a biodegradable polyester composite. The capsule element is selected from the following biodegradable polymers (either pure or in the form of a composite): - Poly(L-lactic acid), PLLA - Poly(L-lactic)-glycolic acid, PLLA-PGA - Poly(lactic-co-glycolic acid), LGA - Polycaprolactone, PCL - Poly(DL-lactic acid), PDLLA It is particularly preferred that the biodegradable polymer comprises or consists of one of the biodegradable polymers listed above.

[0021] These polymers are particularly suitable because of their biodegradable nature and the time delay in biodegradation or bioabsorption by the patient's body. The inner element may be formed from the same material as the capsule element or from a different material, for example, the capsule element may be formed from PDLLA and the inner element may be formed from PCL.

[0022] According to some preferred embodiments, embodiment variants or improvements, the capsule element comprises ceramic, metal and / or bioglass particles. Such particles may in particular be part of various composites or compounds of the capsule element. Such particles may advantageously promote and stimulate tissue regeneration, thereby increasing the therapeutic usefulness of the implant system. The capsule element therefore also offers a very suitable solution for administering such therapeutically useful particles in a precisely positioned and time-delayed manner into the patient's body, without the need for, for example, regular injections.

[0023] According to some preferred embodiments, embodiment variations or improvements, the three-dimensional internal space defined by the capsule element has an inlet opening, which is sized so that soft tissue can be introduced into the internal space through the inlet opening. In this case, in particular, the inlet opening is larger than the passage opening. For example, the inlet opening may have a diameter at its widest point that is more than 10 times, in particular more than 15 times, more than 20 times, or even larger than the diameter (for circular or elliptical pores) or side length (for square or rectangular passage openings) of the largest or smallest passage opening. Preferably, the capsule element includes a plurality of passage openings, for example at least 10, at least 30 passage openings, at least 50 passage openings, more than 100 passage openings, or even more passage openings.

[0024] On the other hand, the capsule element is preferably provided with at most two inlet openings for the soft tissue, particularly preferably exactly one inlet opening for the soft tissue into the internal space. The inlet opening also differs from the passage opening in particular in that the soft tissue is preferably introduced through the inlet opening into the internal space when the implant system, more precisely the capsule element, is attached, whereas the passage of the substance or tissue part through the passage opening occurs gradually only after the implant system has been attached into the patient's body.

[0025] According to some preferred embodiments, embodiment variants or improvements, a retention structure for retaining the implant system, in particular the capsule element, in the patient's body is at least partially formed on the edge of the inlet opening. The retention structure can be formed, for example, by edge shaping or edge inversion, and in some variants can be partially structured or specifically functionalized. The retention structure can include one or more fixation elements, which can be configured, for example, in the form of nails or pin fixation for introduction into hard tissue of the patient's body or in the form of loops for fixing the capsule element on the hard tissue of the patient. In this way, the implant system can be held particularly stably in the patient's body.

[0026] According to some preferred embodiments, embodiment variations or improvements, the implant system further comprises an inner element that is at least partially disposed or disposable within the three-dimensional interior space defined by the capsule element. The inner element can perform multiple functions, and the inner element can comprise, for example, at least one guide structure for cell migration inward. It is also conceivable that the inner element comprises at least one support structure for maintaining the three-dimensional envelope (e.g., three-dimensional curvature) of the capsule element to define the three-dimensional interior space. For example, the inner element can comprise support walls or support columns, such as those corresponding to the interior of a house, or can comprise reinforcing elements, such as ribs on the inside (the side of the capsule element facing the interior), etc. It should be understood that the reinforcing elements (e.g., ribs) can be disposed on the outside of the capsule element.

[0027] The inner element may be constructed integrally with the capsule element and in particular may be manufactured at the same time as the capsule element. Alternatively, the inner element may be constructed separately from the capsule element. In the latter case, the inner element may be detachably, non-detachably or not connected to the capsule element. For example, the inner element may be mounted within the capsule element and then fixed in place by the capsule element when the implant system is implanted in the patient's body.

[0028] According to some preferred embodiments, embodiment variants or improvements, the inner element comprises ceramic particles, metal particles and / or bioglass particles. Such particles may in particular be part of various composites or compounds of the capsule element. Such particles may advantageously promote and stimulate tissue regeneration, thereby increasing the therapeutic utility of the implant system. The particles may also be used as a carrier system for certain growth factors, such as FGF (fibroblast growth factor), IGF-1 (insulin-like growth factor) or CTGF (connective tissue growth factor), and peptide-based variants of these growth factors, thus optimizing soft tissue regeneration by biological activation at site-specific locations due to their spatial arrangement in the implant system.

[0029] The inner element therefore also offers a very suitable solution for the administration of such therapeutically useful particles in a precisely positioned and time-delayed manner into the patient's body, without the need for, for example, regular injections, etc. The inner element (or inner structure) of the implant system can also be produced by the specific introduction of components of the extracellular matrix, for example collagen-based fibrous components, but also fibronectin or hyaluronic acid components, in order to promote and / or improve tissue healing.

[0030] According to some preferred embodiments, embodiment variations or refinements, the interior space of the implant system is at least partially filled with a collagen matrix and / or a biocomposite mixture, which may further promote inward tissue migration. [Brief description of the drawings]

[0031] The invention is explained in more detail below using exemplary embodiments in the figures of the drawings, which show partly schematic representations. [Figure 1] FIG. 1 illustrates an exemplary three-dimensional plan view of an implant system according to an embodiment of the present invention. [Diagram 2] 2 is a schematic cross-sectional view of the implant system according to FIG. 1 in one variant. [Diagram 3] 4 is a schematic flow chart illustrating a manufacturing method according to another embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0032] In all figures, identical or functionally equivalent components and devices are designated with the same reference numbers unless otherwise indicated. FIG. 1 shows an exemplary three-dimensional perspective view of an implant system 100 according to one embodiment of the present invention. The implant system 100 includes a bioabsorbable encapsulation element 110 that includes or consists of a biodegradable or bioabsorbable polymer. Preferably, the encapsulation element 110 includes or consists of a biodegradable or bioabsorbable polyester. Particularly suitable materials that may be used to construct or include the encapsulation element 110 include the following: - Poly(L-lactic acid), PLLA - Poly(L-lactic)-glycolic acid, PLLA-PGA - Poly(lactic-co-glycolic acid), LGA - Polycaprolactone, PCL - Poly(DL-lactic acid), PDLLA.

[0033] Capsule element 110 may preferably comprise ceramic, metallic, and / or bioglass particles, which, among other things, may promote and stimulate tissue regeneration and thus have therapeutic utility.

[0034] As can be seen from Fig. 1, the capsule element 110 has a three-dimensional curvature, i.e. a three-dimensional envelope with no internal curves or edges. In the example shown in Fig. 1, the capsule element 110 is three-dimensionally curved to have the shape of a spherical shell segment, in other words the shape of a spherical cap of a spherical segment. Thus, the capsule element 110 essentially has two surfaces, an outer convex outer surface 111 and an inner concave inner surface 112. In Fig. 1, the outer surface 111 faces towards the viewer and the inner surface 112 faces away from the viewer.

[0035] The capsule element 110 defines a three-dimensional internal space 120 inside the capsule element 110, i.e. in particular along the inner surface 112, for receiving soft tissue. The soft tissue can be, for example, adipose tissue and / or connective tissue. Due to the aforementioned shape of the capsule element 110, the internal space 120 defined by the capsule element 110 has the shape of a spherical segment. Due to the fact that the capsule element 110 is configured in the shape of a spherical shell segment, the three-dimensional internal space 120 is partially open to the outside, i.e. there is an inlet opening 130. The inlet opening 130 is dimensioned such that the soft tissue can be introduced into the internal space 120 through the inlet opening 130. As a result of the geometric shape shown in FIG. 1 and described above, the inlet opening 130 of the capsule element 110 is in this case circular.

[0036] 1 may be used, for example, as a soft tissue implant for breast reconstruction, the curved shape of the capsule element 110 being suitable for fixing the soft tissue received in the internal space 120, giving it a shape suitable for breast reconstruction and maintaining the soft tissue in that shape. It is understood that other, for example less regular, shapes of the capsule element 110 (and thus the shapes of the internal space 120 defined by said capsule element 110 and of the correspondingly defined entrance opening 130) are also possible for soft tissue reconstruction or soft tissue functional improvement in other parts of the body.

[0037] As also shown in FIG. 1, the capsule element 110 preferably comprises a number of passage openings 113 that traverse the capsule element 110 from the outer surface 111 to the inner surface 112. As already mentioned above, these passage openings 113 are advantageously used not only to reduce the mass of the capsule element 110 but also to simultaneously maintain the volume of the interior space 120 defined by the capsule element 110. In addition, the passage openings 113 are also used to allow the exchange of tissue parts or other substances (e.g. fluids) through the capsule element 110. In this way, for example, blood vessels located on the outer surface 111 of the capsule element 110 can grow into the capsule element 110 after the implant system 100 has been installed in the patient's body. Furthermore, for example, an exchange of lymphatic fluids and / or the like can be performed. During the exchange of substances, the ceramic, metal and / or bioglass particles contained in the capsule element 110 can advantageously be dissolved and thus introduced into the interior space 120 and the soft tissue located therein. In this way, tissue ingrowth or cell ingrowth can be further improved.

[0038] As shown in FIG. 1, the passage openings 113 of the capsule element 110 in the illustrated example are all configured with the same diameter and arranged in a mostly uniform lattice structure or matrix-like lattice, which is somewhat interrupted only in the edge regions of the outer surface 111. However, it should be understood that the passage openings 113 may also be configured site-specifically or arranged differently, for example, to build a diffusion barrier at a particular site in the tissue, or to minimize such a diffusion barrier, or to promote diffusion at a defined site. To reduce the diffusion barrier, the passage openings 113 may be configured with a larger diameter or formed with a higher density and in greater numbers relative to each other, while to build or reinforce a diffusion barrier, the exact opposite measures may be taken, except for the portions of the capsule element 110 where the passage openings 113 are not arranged. For example, in FIG. 1, it can be seen that areas without passage openings 113 may be formed near the edges of the outer surface 111.

[0039] 1, it can be seen that the outer surface 111 can be turned at the edge, i.e. on its radial circumference, outward, i.e. towards the outer surface 111. In this way, a retention structure 135 is formed on the capsule element 110 for retaining the implant system 100, in particular the capsule element 110, within the patient's body.

[0040] FIG. 2 shows a schematic cross-sectional view of the implant system 100 according to FIG. 1 in one variant. Fig. 2 clearly shows the edge inversion, which forms a retention structure 135 and in this case extends all around the entrance opening 130. The passage opening 113 is not shown in Fig. 2 for clarity. In the variant shown in Fig. 2, the implant system 100 further comprises a schematic shown inner element 140, which is at least partially disposed or positionable within the three-dimensional interior space 120 defined by the capsule element 110 and comprises at least one guide structure 141 for inward cell migration.

[0041] As already described in detail above, the inner element 140 may be constructed integrally with the capsule element 110 or separately from it. The inner element 140 may be fixed on the capsule element 110 or may be fixable on the capsule element 110 or may be constructed separately and flexibly from the capsule element 110. The inner element 140 itself may be constructed in one piece or may be constructed of various individual elements. The inner element 140 may be constructed from the same material as the capsule element 110 or from different materials, in which case the same materials, composites or combinations of materials as those described in detail above with respect to the capsule element 110 may in principle be envisaged for the inner element 140. In particular, the inner element 140 may also comprise ceramic, metallic and / or bioglass particles in order to promote and stimulate tissue regeneration and thereby provide additional therapeutic benefits.

[0042] As shown in FIG. 2 , individual portions of inner element 140 may not only function as guide structures 141 but may also, optionally, function as one or more support structures for maintaining the three-dimensional envelope of capsule element 110, i.e., for maintaining the curvature of capsule element 110.

[0043] In FIG. 2, the guide structure 141 is represented as being relatively coarsely constructed, but it should be understood that it may be formed with any complex and fine structure. The inner element 140 and / or individual parts of the inner element 140, for example, any support structure of the inner element 140 in particular, may be constructed differently from the capsule element 110 in terms of biodegradability over time. In this case, the various time sequences of biodegradation may be specifically adapted to the planned intended use, for example, the capsule element 110 may be intended to degrade before the inner element 140, or vice versa. Also, individual parts or sections of the inner element 140 may be intended to degrade at different rates, for example, to provide the interior space 120 with a volume for inward tissue migration in a stepwise manner, while the ordering or support function of the inner element 140 may be reduced by the inward tissue migration. The interior space 120 may be at least partially or completely filled with a collagen matrix and / or a biocompatible composite mixture to further support inward cell migration or inward tissue migration.

[0044] Fig. 3 shows a schematic flow chart for illustrating a method for manufacturing an implant system 100 according to another embodiment of the present invention. The method according to Fig. 3 may be used for manufacturing the implant system 100 shown in Fig. 1 or Fig. 2 and may be adapted and / or modified accordingly according to everything related to the present invention, in particular the implant systems according to Fig. 1 and Fig. 2, and vice versa.

[0045] In step S10, the anatomical structure of the human patient is measured to obtain anatomical data. The anatomical data may include, for example, the thickness and location of one or more types of tissue, the dimensions of the soft tissue defect site, and / or the like. In step S20, a patient-specific implant system 100 is created based on the anatomical data, i.e., is first planned and then manufactured according to the plan. The capsule element 110 of the implant system 100 may in particular be manufactured by thermoforming. The optionally provided inner element 140, which is not configured integrally with the capsule element 110, may either be connected to the capsule element 110 before implantation and then implanted together with the capsule element 110, or simply installed inside the patient's body and then connected to the capsule element 110 in situ.

[0046] Although the present invention has been described based on preferred embodiments, the present invention is not limited thereto and can be modified in various different ways. In particular, the present invention can be modified or amended in many ways without departing from the essential gist of the present invention. [Explanation of symbols]

[0047] 100…Implant system 110…Capsule element 111...External surface 112…Inner 113...Aisle opening 120…Interior space 130...Inlet opening 135...Holding structure 140…Inner element 141...Guide structure

Claims

1. An implant system (100) comprising at least one bioabsorbable capsule element (110), the at least one bioabsorbable capsule element (110) configured with a passage opening (113) and defining a three-dimensional interior space (120) for receiving soft tissue.

2. The implant system (100) of claim 1, wherein the bioabsorbable capsule element (110) is configured as a geometrically stable capsule element prior to the onset of bioabsorption.

3. 3. The implant system (100) of claim 1 or 2, wherein the three-dimensional interior space (120) is defined and at least partially enclosed by a three-dimensional curvature of a capsule element (110).

4. An implant system (100) according to any one of the preceding claims, wherein the passage openings (113) are provided by pores and / or a matrix-like lattice.

5. The implant system (100) of claim 4, wherein the pores and / or the matrix-like lattice are at least partially uniformly arranged or configured.

6. An implant system (100) according to any one of claims 1 to 5, wherein the capsule element (110) comprises or consists of a biodegradable polymer (in particular comprises or consists of a biodegradable polyester).

7. The implant system (100) of claim 6, wherein the capsule element (110) comprises or consists of PLLA, PLLA-PGA, PLGA, PCL and / or PDLLA.

8. The implant system (100) of any one of claims 1 to 7, wherein the capsule element (110) comprises ceramic particles, metal particles, and / or bioglass particles.

9. 9. The implant system (100) of any one of claims 1 to 8, wherein the three-dimensional internal space (120) defined by the capsule element (110) has an entrance opening (130), the entrance opening (130) being sized such that the soft tissue can be introduced into the internal space (120) through the entrance opening (210).

10. 10. The implant system (100) of claim 9, wherein a retention structure (135) for retaining the implant system (100) within a patient's body is at least partially formed on an edge of the entrance opening (130).

11. An implant system (100) as described in any one of claims 1 to 10, further comprising an inner element (140) that is at least partially positioned or positionable within the three-dimensional internal space (120) defined by the capsule element (110) and has at least one guide structure (141) for inward cell migration.

12. 12. The implant system (100) of claim 11, wherein the inner element (140) has at least one support structure for maintaining a three-dimensional envelope of the capsule element (110) to define the three-dimensional interior space (120).

13. 13. An implant system (100) according to claim 11 or 12, wherein the inner element (140) is configured integrally with the capsule element (110) or configured separately from the capsule element (110).

14. The implant system (100) of any one of claims 11 to 13, wherein the inner element (140) comprises ceramic particles, metal particles, and / or bioglass particles.

15. 15. An implant system (100) according to claim 14, wherein the ceramic, metal and / or bioglass particles are used as a carrier system for certain growth factors, in particular FGF, IGF-1 or CTGF, or peptide-based variants of these growth factors.

16. 16. An implant system (100) according to any one of the preceding claims, wherein the interior space (120) is at least partially filled with a collagen matrix and / or a biocompatible composite mixture.

17. A method of manufacturing an implant system (100), comprising the steps of: - measuring the anatomy of a human patient to obtain anatomical data (S10); and creating (S20) a patient-specific implant system (100) based on said anatomical data, wherein a capsule element (110) of said implant system (100) is preferably manufactured by thermoforming.